FTSJD2 Inhibitors
FTSJD2 Inhibitors encompasses a range of chemical compounds known to interfere with cellular signaling mechanisms, ultimately leading to the reduced activity of the protein FTSJD2. These inhibitors vary widely in their targets and mechanisms of action, reflecting the complexity of cellular signaling pathways and the multitude of potential regulatory points that could be exploited to modulate protein function. Compounds such as H-89, Staurosporine, and Wortmannin are representative of kinase inhibitors, which can reduce the activation of proteins by inhibiting their phosphorylation, a common regulatory mechanism for protein activity.
In addition to kinase inhibition, other mechanisms of action are present within this class, such as the reduction of second messenger production (U73122 inhibiting phospholipase C), blockade of intracellular calcium release (2-APB blocking IP3 receptors), and specific inhibition of signaling proteins like mTOR (Rapamycin). Through these diverse mechanisms, these chemicals can lead to a decrease in the activity of various proteins that are downstream of the targeted signaling pathways, reflecting the potential for indirect inhibition of FTSJD2 activity. The specificity of some inhibitors, such as PD98059 for MEK or SB203580 for p38 MAP kinase, highlights the precision with which signaling pathways can be modulated to achieve desired changes in protein activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
A potent inhibitor of protein kinase A (PKA), it prevents phosphorylation of target proteins, potentially reducing the activity of proteins regulated by PKA. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A broad-spectrum kinase inhibitor, known to inhibit a variety of protein kinases, which could decrease phosphorylation-mediated protein activation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A selective inhibitor of MEK, which is upstream of the ERK pathway, possibly reducing the phosphorylation and activity of proteins that are controlled by this pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3 kinase, which may lead to reduced activation of downstream signaling proteins including AKT, potentially lowering the activity of proteins regulated by this pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Specifically binds to mTOR and inhibits its activity, which may downregulate several downstream signaling cascades, potentially affecting the activity of proteins regulated by mTOR signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which can lower the phosphorylation of proteins in the JNK signaling pathway, potentially decreasing the activity of target proteins regulated by this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A specific inhibitor of p38 MAP kinase, potentially reducing the activity of proteins regulated by the p38 MAPK pathway through decreased phosphorylation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A potent inhibitor of PI3K, which may decrease AKT phosphorylation and subsequent protein activity in the PI3K/AKT signaling pathway. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
A potent PKC inhibitor, which could reduce protein phosphorylation and activity within the PKC signaling pathway. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
Inhibits PKC, potentially leading to decreased phosphorylation and activity of proteins involved in the PKC signaling pathway. | ||||||